Formation of an N-formylkynurenine-derived fluorophore and its use for measuring indoleamine 2,3-dioxygenase 1 activity (Q34546698)

2 August 2017

title

Formation of an N-formylkynurenine-derived fluorophore and its use for measuring indoleamine 2,3-dioxygenase 1 activity (English)

1 reference

2 August 2017

2

Brian D Palmer

1 reference

2 August 2017

Petr Tomek

1

1 reference

2 August 2017

Jack U Flanagan

3

1 reference

2 August 2017

Sai-Parng S Fung

4

1 reference

2 August 2017

David J A Bridewell

5

1 reference

2 August 2017

Joanne F Jamie

6

1 reference

2 August 2017

Lai-Ming Ching

7

1 reference

2 August 2017

language of work or name

English

0 references

publication date

12 January 2013

1 reference

Analytical and Bioanalytical Chemistry

2 August 2017

published in

1 reference

2 August 2017

volume

405

1 reference

2 August 2017

issue

8

1 reference

2 August 2017

page(s)

2515-2524

1 reference

https://scigraph.springernature.com/pub.10.1007/s00216-012-6650-y

2 August 2017

exact match

0 references

cites work

Heme-Containing Oxygenases

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

The mechanism of formation of N-formylkynurenine by heme dioxygenases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

Endogenous kynurenines as targets for drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

Tryptophan degradation and immune activation in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

Increased neopterin production and tryptophan degradation in advanced Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

Cancer: Why tumours eat tryptophan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

Immune escape as a fundamental trait of cancer: focus on IDO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

High expression of indoleamine 2,3-dioxygenase gene in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

Upregulated expression of indoleamine 2, 3-dioxygenase in primary breast cancer correlates with increase of infiltrated regulatory T cells in situ and lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

Marrying immunotherapy with chemotherapy: why say IDO?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

Reinstalling antitumor immunity by inhibiting tumor-derived immunosuppressive molecule IDO through RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

Indoleamine 2,3-dioxygenase. A new, rapid, sensitive radiometric assay and its application to the study of the enzyme in rat tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

Simultaneous determination of tryptophan and kynurenine in serum by HPLC with UV and fluorescence detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

A fluorescence-based assay for indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

Homogeneous fluorescence readouts for miniaturized high-throughput screening: theory and practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

Optimised expression and purification of recombinant human indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

Spectroscopic and equilibrium studies of ligand and organic substrate binding to indolamine 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

Tryptophan metabolites interfere with the Ehrlich reaction used for the measurement of kynurenine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6650-Y

10.1007/S00216-012-6650-Y

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference